{"url_path":"/sec/pvct/8-k/2026-06-18/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-18","source_url":"https://www.sec.gov/Archives/edgar/data/315545/0001493152-26-029280-index.html","accession_number":"0001493152-26-029280","cik":"0000315545","ticker":"PVCT","issuer_name":"PROVECTUS BIOPHARMACEUTICALS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/315545/0001493152-26-029280-index.html","primary_entity_key":"0000315545","primary_entity_name":"PROVECTUS BIOPHARMACEUTICALS, INC."},"word_count":87,"has_tables":true,"body_markdown":"**Item\n9.01. Financial Statements and Exhibits.**\n\n \n\n(d)\nExhibits.\n\n \n\nExhibit\nNumber\n \nDescription\n\n99.1\n \n[2026 Annual Meeting of Stockholders presentation slides](ex99-1.htm)\n\n104\n \nCover\nPage Interactive Date File (the cover page XBRL tags are embedded within the inline XBRL document).\n\n** **\n\n \n\n \n\n** **\n\n**SIGNATURE**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\nDate:\nJune 18, 2026\n\n \n\n \n**PROVECTUS\nBIOPHARMACEUTICALS, INC.**\n\n \n \n \n\n \nBy:\n*/s/\nHeather Raines*\n\n \n \nHeather\nRaines\n\n \n \nChief\nFinancial Officer (Principal Financial Officer)\n\n** **\n\n \n\n** **"}